Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

How Big Is the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Expected to Be, and What Will Its Growth Rate Be?
The market size for contract development and manufacturing organization (CDMO) of advanced therapy medicinal products has swiftly accelerated in the recent past. The market value is set to rise from $5.31 billion in 2024 to $6.22 billion in 2025, suggesting a compound annual growth rate (CAGR) of 17.0%. Several factors have contributed to its historical growth, such as an upsurge in ATMP clinical trials, growing recognition and confidence amongst researchers regarding the positive impacts of advanced therapy, the existence of several ATMP CDMOs, intensified efforts towards the development of revolutionary treatments for various diseases, and supportive governmental initiatives.

Over the coming years, the market size for the advanced therapy medicinal products contract development and manufacturing organization (CDMO) is anticipated to witness a fast-paced expansion. It's predicted to surge up to $11.53 billion by 2029, with a compound annual growth rate (CAGR) of 16.7%. This projected growth during the forecast period can be credited to factors such as significant investments from CDMOs, the rise of new players in the cell and gene therapy (CGT) arena, increased grants and investments towards the evolution of cell and gene therapies, an uptick in pharmaceutical R&D expenditure, and a rising number of clinical trials for ATMPs. Key trends expected during the forecast period comprise advancements in AAV biomanufacturing facilities, scaling up of cell and gene therapy manufacturing, technological progress in cell and gene therapy, surging demand for access to cutting-edge platforms and technologies, and the integration of superior technologies like CRISPR and next-gen sequencing for enhanced precision.

What Factors Are Fueling Growth in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The surge in clinical trials is set to fuel the expansion of the advanced therapy medicinal products CDMO market. Clinical trials, research studies carried out on humans to assess the efficacy and safety of medical procedures like treatments, drugs, devices, or preventive strategies, are on the rise due to the growing demand for novel therapies and the escalating global disease load. Advanced therapy medicinal products increase the need for CDMO manufacturing services, calling upon specialized skill sets and facilities. The data derived from clinical trials is invaluable in refining manufacturing, ensuring scalability, and maintaining quality to accommodate broader clinical and commercial demands. As per the Association of the British Pharmaceutical Industry, a UK-based trade association, the total number of industry-conducted clinical trials in the UK rose marginally by 4.3%, from 394 in 2021 to 411 in 2022, reported in November 2023. Consequently, the surge in clinical trials is propelling the expansion of the advanced therapy medicinal products CDMO market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp

Who Are the Dominant Companies Influencing Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Trends?
Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Merck KGaA, Resonac Corporation, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions

How Is the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Evolving?
Leading companies in the advanced therapy medicinal products CDMO market are evolving their cell therapy production services to address pivotal challenges in cell treatment manufacturing and expedite their partners' development proceedings. Contract development and manufacturing organization services offer a wide range of services beginning from elementary preclinical development to the final stage of clinical trials and market distribution. For example, in January 2024, Pluristem Therapeutics Inc., a biotech company from Israel specializing in cellular solutions, initiated PluriCDMO, a new division dedicated to cell therapy manufacturing. The division uses an innovative patented bioreactor system that supports 3D cell replication, enabling the creation of diverse cell types such as stem cells, induced pluripotent stem cells, exosomes, and immune treatments. PluriCDMO is committed to delivering top-quality, essential medicines for patients while keeping up a unique consistency from batch to batch. They aim to do so in a scalable, cost-effective manner and under good manufacturing practice standards.

What Are the Different Segmentations in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market covered in this report is segmented -

1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology

Subsegments:
1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-contract-development-and-manufacturing-organization-cdmo-global-market-report

Which Region Is at the Forefront of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Global Market Report?

- Market Size Analysis: Analyze the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15719

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.